Low numbers and no loss of melanized nigral neurons with increasing age in normal human brains from India

Annals of Neurology

Volumn 43, Issue 3, 1998, Pages 283-287

  Muthane, Uday ^a   Yasha, T C ^a   Shankar, S K ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

MELANIN;

ADOLESCENT; ADULT; AGED; AGING; ARTICLE; CELL COUNT; CELL DENSITY; CELL LOSS; CHILD; FEMALE; HUMAN; HUMAN TISSUE; INDIA; MALE; NERVE CELL DEGENERATION; NIGRONEOSTRIATAL SYSTEM; PARKINSON DISEASE; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGING; CELL COUNT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INDIA; INFANT; INFANT, NEWBORN; MALE; MELANINS; MIDDLE AGED; REFERENCE VALUES; SUBSTANTIA NIGRA;

EID: 0031914408     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410430304     Document Type: Article

References (23)

1. Tanner CM. Epidemiological clues to the cause of Parkinson's disease. In: Marsden CD, Fahn S, eds. Movement disorders, vol 3. Oxford, UK: Butterworth-Heinemann, 1994:124-146
2. Schoenberg BS, Anderson DW, Haerer AF. Prevalence of Parkinson's disease in the biracial population of Copiah County, Mississipi. Neurology 1985;35:841-845
3. Morgante L, Rocca WA, Di Rosa AE, et al. Prevalence of Parkinson's disease and other types of parkinsonism: a door-to-door survey in three Sicilian municipalities. The Sicilian NeuroEpidemiologic Study (SNES) Group. Neurology 1992;42: 1901-1907
4. Schoenberg BS, Osuntokun BO, Adeuja AOG, et al. Comparison of the prevalence of Parkinson's disease in black populations in the rural United States and in rural Nigeria: door-to-door community studies. Neurology 1988;38:645-646
5. Li SC, Schoenberg BS, Wang CC, et al. A prevalence survey of Parkinson's disease and other movement disorders in the People's Republic of China. Arch Neurol 1985;42:655-657
6. Razdan S, Kaul RL, Motta A, et al. Epidemiology of neurological disorders in Kashmir. Neuroepidemiology 1994;13:113-119
7. Gourie-Devi M, Gururaj P, Satishchandra P. Bangalore urban and rural neurological survey. Report submitted to the Indian Council of Medical Research, 1995
8. Das SK, Sanyal K. Neuroepidemiology of major neurological disorders in rural Bengal. Neurology (India) 1996;44:47-58
9. Bharucha NE, Bharucha EP, Bharucha AE, et al. Prevalence of Parkinson's disease in the Parsi community of Bombay, India. Arch Neurol 1988;45:1321-1323
10. Hirsch EC, Graybiel AM, Agid Y. Melanized dopaminergic neurons are differentially affected in Parkinson's disease. Nature 1988;334:345-348
11. McGeer PL, McGeer EG, Suzuki JS. Aging and extrapyramidal function. Arch Neurol 1977;34:33-35
12. Fearnley JM, Lees AJ. Ageing and Parkinson's disease: substantia nigra regional activity. Brain 1991;114:2283-2301
13. Mann DMA, Yates PO. Lipoprotein pigments - their relationship to ageing in the human nervous system. II. The melanin content of pigmented nerve cells. Brain 1974;97:489-498
14. Muthane UB, Swamy HS, Satishchandra P, et al. Early onset Parkinson's disease: are juvenile- and young-onset different? Mov Disord 1994;5:539-544
15. Parkinson's Study Group. Cerebrospinal fluid homovanillic acid in the DATATOP study on Parkinson's disease. Arch Neurol 1996;52:237-245
16. Fahn S. The endogenous toxin hypothesis of the etiology of Parkinson's disease and a pilot trial of high-dosage antioxidants in an attempt to slow the progression of the illness. Ann NY Acad Sci 1989;570:186-196
17. McGeer PL, Itagaki S, Akiyama H, McGeer EG. Rate of cell death in parkinsonism indicates active neuropathological process. Ann Neurol 1988;24:574-576
18. Gibb WRG, Lees AJ. Pathological clues to the cause of Parkinson's disease. In: Marsden CD, Fahn S, eds. Movement disorders, vol 3. Oxford, UK: Butterworth-Heinemann, 1997:147-166
19. Przedborski S, Jackson-Lewis V, Kostic V, et al. Superoxide dismutase, catalase and glutathione peroxidase activities in copper/zinc superoxide dismutase transgenic mice. J Neurochem 1992; 58:1760-1767
20. Riachi NJ, Behmand RA, Harik SI. Correlation of MPTP neurotoxicity in vivo with oxidation of MPTP by the brain and blood-brain barrier in vitro in five rat strains. Brain Res 1991; 555:19-24
21. Riachi NJ, Harik SI. Strain differences in systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in mice correlate best with monoamine oxidase activity at the blood-brain barrier. Life Sci 1988;42:2359-2362
22. Pakkenberg B, Moller A, Gundersen HJG, et al. The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method. J Neurol Neurosurg Psychiatry 1991;54: 30-35
23. Kubis N, Faucheux BA, Ransmayr G, et al. Dopaminergic neuron numbers in midbrain cell groups, between the ages of 44 and 101 years in controls individuals with reference to Parkinson's disease. Mov Disord 1997;12(suppl 1):79 (Abstract)